This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kiaris, H. Articles by Kalofoutis, A. Search for Related Content PubMed PubMed Citation Articles by Kiaris, H. Articles by Kalofoutis, A.

Evidence for Nonautonomous Effect of p53 Tumor Suppressor in Carcinogenesis

¹ Department of Biological Chemistry and ² Department of Pathology, Aretaieion Hospital, University of Athens Medical School, Athens, Greece

Requests for reprints: Hippokratis Kiaris, Department of Biological Chemistry, University of Athens Medical School, 75 M. Asias Street, 115 27 Athens, Greece. Phone: 30-210-746 2695; Fax: 30-210-746 2695; E-mail: hkiaris{at}med.uoa.gr.

Prostate, breast, and probably other epithelial tumors harbor inactivating mutations in the p53 tumor suppressor gene in the stromal cells, implying the nonautonomous action of p53 in carcinogenesis. We have tested this hypothesis by evaluating the tumorigenicity of MCF7 human breast cancer cells in severe combined immunodeficient mice that differ in their p53 status. Our results showed that, indeed, p53 ablation in the hosts reduced the latency for the development of MCF7 tumors. Furthermore, we show that heterozygous hosts frequently undergo loss of heterozygosity at the p53 locus in the tumor stroma tissue by mechanism that resembles the inactivation of p53 in primary tumors. To evaluate the impact of p53 ablation in the stromal fibroblasts, in tumorigenesis, tumors were reconstituted in mice bearing wild-type p53 alleles, by mixing MCF7 cells with fibroblasts isolated from mutant or wild-type p53 mice. Our results suggest that tumors containing p53-deficient fibroblasts developed faster and were more aggressive than their counterparts with wild-type fibroblasts, although their neoplastic component, namely MCF7 mammary carcinoma cells, was identical in both cases. These data strongly support the notion for the operation of a nonautonomous mechanism for p53 action in primary tumors and provide a mechanistic association between p53 mutations in the stromal component of epithelial tumors and carcinogenesis.

Key Words: stroma • fibroblasts • mutations • nonautonomous • xenografts

This article has been cited by other articles:

				N. M. Hawsawi, H. Ghebeh, S.-F. Hendrayani, A. Tulbah, M. Al-Eid, T. Al-Tweigeri, D. Ajarim, A. Alaiya, S. Dermime, and A. Aboussekhra Breast Carcinoma-Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes Cancer Res., April 15, 2008; 68(8): 2717 - 2725. [Abstract] [Full Text] [PDF]

				P. Secchiero, F. Corallini, E. Rimondi, C. Chiaruttini, M. G. di Iasio, A. Rustighi, G. Del Sal, and G. Zauli Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells Blood, February 1, 2008; 111(3): 1287 - 1294. [Abstract] [Full Text] [PDF]

				E. Drakos, A. Thomaides, L. J. Medeiros, J. Li, V. Leventaki, M. Konopleva, M. Andreeff, and G. Z. Rassidakis Inhibition of p53-Murine Double Minute 2 Interaction by Nutlin-3A Stabilizes p53 and Induces Cell Cycle Arrest and Apoptosis in Hodgkin Lymphoma Clin. Cancer Res., June 1, 2007; 13(11): 3380 - 3387. [Abstract] [Full Text] [PDF]

				N. Moskovits, A. Kalinkovich, J. Bar, T. Lapidot, and M. Oren p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts. Cancer Res., November 15, 2006; 66(22): 10671 - 10676. [Abstract] [Full Text] [PDF]